Hot flush pill gets green light for UK use
The treatment, made by Bayer, can be given to women who have vasomotor symptoms, also known as hot flushes, as an alternative to hormone replacement therapy (HRT).
HRT can help relieve most menopause and perimenopause symptoms, including hot flushes.
But not all patients want or are able to take hormone treatments.
At present elinzanetant is not available on the NHS but the green light from the MHRA means that it can be purchased privately in the UK.
It is to be considered by the NHS spending watchdog, the National Institute for Health and Care Excellence.
Hot flushes and night sweats are one of the most common symptoms of menopause.
It is understood that as oestrogen levels decline around menopause, the body's temperature regulation system can be disrupted when certain brain cells become overactive.
The new treatment, which is a non-hormonal medication, works by calming these signals in the brain.
Clinical trial data showed that the drug was safe and well tolerated and reduced hot flushes compared with a dummy drug, also known as a placebo.
You may not have reached #menopause if you're experiencing headaches, night sweats, weight gain, anxiety and depression – but you may be #perimenopausal. Take a look on our website for more information 👉 https://t.co/hw2P09ZPA6 pic.twitter.com/zvbXIWXh3C
— Patient (@patient) May 22, 2023
It was also linked to fewer sleep disturbances and women taking it reported a better quality of life compared with those taking the placebo.
'Hot flushes and night sweats associated with menopause can have a significant negative impact on quality of life,' said Julian Beach, the MHRA's interim executive director of healthcare quality and access.
'We are therefore pleased to announce our approval of elinzanetant, which has met the MHRA's standards for safety, quality and effectiveness.
'Elinzanetant offers a non-hormonal alternative for those who may not be able to, or prefer not to, take hormone-based therapies.
'As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used.'
Women usually go through the menopause when they are aged between 45 and 55, though it can start sooner.
During the menopause a woman's periods stop due to lower hormone levels.
Menopause and perimenopause can cause symptoms including anxiety, mood swings, brain fog, hot flushes and irregular periods.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
an hour ago
- Daily Record
Dogs can detect incurable disease years before signs appear with near 100% accuracy
The lead author of the study said dogs' ability to sniff out the condition, that affects thousands of Scots, were "well above chance" Dogs are wonderful creatures and there is a reason they are often referred to as man's best friend. Most canines are loyal, affectionate, and there for you in times of hardship. And there is perhaps no tougher time than when you're ill. Now, new research has uncovered an astounding fact about pooches that could change the way we approach Parkinson's disease in Scotland, of which around 13,000 people have been diagnosed, and the number is growing, according to Parkinson's UK. Parkinson's disease is a condition in which parts of the brain become progressively damaged over many years, according to the NHS. The main symptoms are tremors, slow movement, and stiff and inflexible muscles. A person with Parkinson's disease can also experience depression and anxiety, balance problems, loss of smell, insomnia, and memory problems. However, the new study has proved that people with Parkinson's disease have an odour that can be reliably detected from skin swabs by trained dogs. In a double-blind trial, the animals identified skin swabs from people with Parkinson's with up to 80 per cent sensitivity and 98 per cent specificity, even when other health conditions were present. The findings offer hope for a simple, non-invasive diagnostic method using biomarkers that appear long before traditional symptoms, potentially allowing earlier treatment and slowed disease progression. "We are extremely proud to say that once again, dogs can very accurately detect disease," said Claire Guest, Medical Detection Dogs CEO and Chief Scientific Officer. "There is currently no early test for Parkinson's disease and symptoms may start up to 20 years before they become visible and persistent leading to a confirmed diagnosis. Timely diagnosis is key as subsequent treatment could slow down the progression of the disease and reduce the intensity of symptoms." The Medical Detection Dogs and the Universities of Bristol and Manchester research was published on July 15 in The Journal of Parkinson's Disease. The study's two dogs were Golden Retriever, Bumper and Black Labrador, Peanut. Bumper and Peanut were trained by the charity, Medical Detection Dogs, to distinguish between sebum swabs from people with and without Parkinson's. As mentioned, in a double blind trial, they showed sensitivity of up to 80 per cent and specificity of up to 98 per cent. And not only that - they also detected it in samples from patients who also had other health conditions. The dogs were trained over a number of weeks on over 200 odour samples from individuals that had tested positive for PD and control samples from people who did not have the disease. Samples were presented to the dogs on a stand system and the dogs were rewarded for correctly indicating a positive sample and for correctly ignoring a negative sample. In the double-blind testing, meaning that only a computer knew where the correct samples were, each line was also presented in reverse order so that samples for which no decision was made were re-presented. Then any unsearched samples were collected together in new lines, until a decision had been made for all samples. Join the Daily Record WhatsApp community! Get the latest news sent straight to your messages by joining our WhatsApp community today. You'll receive daily updates on breaking news as well as the top headlines across Scotland. No one will be able to see who is signed up and no one can send messages except the Daily Record team. All you have to do is click here if you're on mobile, select 'Join Community' and you're in! If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose 'exit group'. A definitive diagnostic test for Parkinson's does not yet exist, so identification of potential biomarkers could help diagnosis and timely intervention. Nicola Rooney, Associate Professor at Bristol Veterinary School and lead author, said: "Sensitivity levels of 70 per cent and 80 per cent are well above chance. "I believe that dogs could help us to develop a quick non-invasive and cost-effective method to identify patients with Parkinson's disease."
BBC News
an hour ago
- BBC News
Go for your check-ups, father with prostate cancer urges men
A father-of-three has advised men not to put off routine check-ups after his own doctor's visit revealed he had stage three prostate maker Neil Maggs, 50, told BBC Radio Bristol presenter Joe Sims he could have died within 18 months had he not had prostate removal surgery in March last year."Just go and get it done – it's better to be alive," said Mr Maggs, from Fishponds in also spoke about the physical repercussions of the operation, which he said were "a massive wake-up call", affecting his mental health and sense of identity. "If your identity is, 'I'm a man, I'm a virile man', then suddenly you're having to wear a nappy at the age of 50 and can't get an erection, it becomes like a midlife crisis," he said. Symptoms of prostate cancer do not usually appear until the prostate is large enough to affect the tube that carries urine, according to the disease tends to affect over-50s, and although there is not a definitive test for it, a prostate-specific antigen (PSA) test can indicate whether cancer is the cancer is slow-growing, it can be there for decades before it is presenter Dermot Murnaghan, cyclist Chris Hoy and former US President Joe Biden are all living with prostate Maggs said he was convinced into going for a routine check-up for over-40s in January 2024, after telling a nurse he urinated later had to have a biopsy – which he described as "arguably the worst part" of his experience."The needle to numb you, it felt like someone was squeezing my balls, and punching me in the face at the same time," he said. The diagnosis came back within a week. "The moment I knew was when the nurse came out and bowed her head."I was basically near to stage four, on stage three and a half – stage four is basically fatal where you need palliative care and you will die from it," he the time his surgery was scheduled, he had "fallen into a sense of thinking, 'this could be it'"."I was kind of ready for the possibility," he said. "I wanted to be present and be with my family – it's a feeling that's kind of stayed with me." 'Moments that get you' But Mr Maggs, whose children are 13, nine and eight, said nothing could have prepared him for the mental struggle after the prostate removal surgery."For some men who have never faced their demons, it's a massive wake-up call," he said after the operation "there are moments that can get you". "I was less prepared for that," he said. "Your testosterone is less so there is a physical thing that affects your mental health."Mr Maggs said "quite a few of my mates and family have had a check-up" following his diagnosis and surgery. He now has a PSA check every two months and has been told his current levels and prognosis are both good.
The Independent
an hour ago
- The Independent
Concerns major new NHS reforms to GP appointments will make no difference
Nearly half of the public believes the government's ambitious 10-year plan to overhaul the nation's health will either make no difference or exacerbate the difficulty of securing a GP appointment, a new survey has found. The Ipsos poll, conducted for the PA news agency, also revealed that more than four in 10 respondents anticipate no improvement in A&E waiting times. Despite this widespread scepticism, the blueprint has garnered significant support for several key proposals, including the establishment of neighbourhood health centres, the expansion of the NHS app, and increased mental health provision in educational settings. Unveiled by Prime Minister Sir Keir Starmer earlier this month, the strategy aims to shift healthcare provision closer to people's homes, thereby reducing the current reliance on hospitals and emergency departments. Central to the reforms are plans for an enhanced NHS app, designed to give patients greater control over their care, alongside new neighbourhood health centres slated to operate six days a week for at least 12 hours daily. The plan also includes proposals for new legislation concerning food and alcohol, intended to proactively prevent ill health. The survey, which polled 1,023 adults across Britain, specifically questioned public perceptions on how the plan would affect access to GP services, A&E waiting times, and routine hospital treatment. Some 35 per cent said the plan will have no impact on getting a GP appointment, while 14 per cent believe it will make things harder. This compares with the 29 per cent of people who said they think it will make getting an appointment easier. More than a third (37 per cent) said it will make no difference to waiting times in emergency departments, while almost one in 10 (9 per cent), said they believe it could worsen waiting times, compared with 30 per cent who said it will improve them. Meanwhile, 31 per cent said the plan will have no impact on waiting times for hospital treatment, 11 per cent believe the plan will worsen waiting times and 34 per cent said they think the measures will help. However, a number of proposals outlined in the plan were strongly backed by the public. Some 84 per cent said they supported the creation of a single patient record, while 78 per cent backed the creation of neighbourhood health centres, 73 per cent support the expansion of the NHS app and 72 per cent are in favour of more mental health support in schools and colleges. However, more than a quarter (27 per cent) of people do not support making hospitals fully AI enabled, compared with 44 per cent who would back the move. Almost one in five (18 per cent) said they would not support so-called 'patient power payments', which would allow patients to hold back some of the payment for their care if they are not satisfied, while 42 per cent would support the measure. Some proposals aimed at helping people to lead healthier lives were also strongly supported. A ban on the sale of high-caffeine energy drinks was backed by 78 per cent of people, while 69 per cent back plans to restrict junk food advertising. However, almost one in five (18 per cent) tended to disagree with measures that could see alcoholic drinks labelled with nutritional information, although 57 per cent backed the move. One in four people think the measures included in the plan will make no difference to patients, the poll found. Almost one in 10 (9 per cent) said they think the changes will make things worse, while 35 per cent believe it will improve the health service. A similar proportion, 23 per cent, said the 10-year health plan will make no difference to NHS staff, while 13 per cent said it could make things worse and 33 per cent believe it will have a positive effect. A Department of Health and Social Care spokesperson said: 'We're getting on with the job of delivering for patients, with NHS waiting lists falling by 260,000 since July 2024, delivering more than 4.6 million additional appointments since the general election and recruiting over 1,900 extra GPs to fix the front door of the NHS. 'Backed by an additional £29 billion, our 10-year health plan will seize the opportunities provided by new technology, medicines and innovation to deliver better care for all patients, no matter where they live or how much they earn, and better value for taxpayers. 'It is no surprise the plan is popular with patients, it was the result of the biggest conversation with staff, patients and the public since the formation of the NHS, with more than a quarter of a million contributions.'
